
RANOLAZINE
Ranolazine extended-release tablets are an antianginal indicated for the treatment of chronic angina. (1) Ranolazine extended-release tablets are indicated for the treatment of chronic…
Ranolazine extended-release tablets are an antianginal indicated for the treatment of chronic angina. (1) Ranolazine extended-release tablets are indicated for the treatment of chronic…
Rifabutin capsules USP are indicated for the prevention of disseminated Mycobacterium avium complex (MAC) disease in patients with advanced HIV infection. CONTRAINDICATIONS: Rifabutin…
In the treatment of both tuberculosis and the meningococcal carrier state, the small number of resistant cells present within large populations of susceptible cells can rapidly become the…
Pediatric use information for patients 7 to 17 years of age is approved for AstraZeneca’s CRESTOR (rosuvastatin calcium) tablets. However, due to AstraZeneca’s marketing exclusivity…
Rufinamide tablets USP are indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome (LGS) in pediatric patients 1 year of age and older, and in adults (1)…
As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.
Terms of Use | Copyright © 2023. All Rights Reserved.